Dr. John ‘Jeep’ Baggett is a biochemist with expertise in scientific communication, data visualization, and data analysis. He received his B.S. in Biochemistry and Molecular Biology and his Ph.D. in Biochemistry from the University of Nevada, Reno. His doctoral work focused on sub-population molecular marker development and plant abiotic stress. This work involved field, greenhouse, laboratory, and in silico experimentation. Before joining Gryphon in 2022, Dr. Baggett worked for the Nevada Department of Agriculture as the Education and Information Officer, analyzing agricultural data, producing reports, and interacting with stakeholders. At Gryphon, Dr. Baggett focuses on projects in data management and communications.

Dr. Dylan McClung is a microbiologist with expertise in natural product discovery and antibiotic resistance. He received his PhD from the University of California, Berkeley, where his interdisciplinary research spanned microbial ecology, natural product chemistry, genetics/genomics, and molecular protein modeling. In graduate school, he began performing as Dyna Cockus Rose, which allowed him to combine the art of drag and science communication on an international scale. At Gryphon, Dr. McClung focuses on science communications and outreach, with an emphasis on social media, to support influenza, coronavirus, and translational science research.

Dr. Holly May is a microbiologist with an expertise in infectious disease and host-pathogen interactions. At Gryphon, her work focuses on scientific data management and analysis to support influenza and coronavirus surveillance and research. Prior to joining Gryphon, Dr. May received her PhD in Cell and Molecular Biology from the University of Texas at San Antonio and completed her post-doctoral training at the Naval Medical Research Unit-San Antonio, where her research focused on multi-drug resistant bacteria and bacteriophage therapy. She also previously served as a Young Ambassador to the American Society for Microbiology, where she worked on community outreach and education initiatives.

Dr. Glen Noble brings to Gryphon over 20 years of experience in medicinal chemistry and 17 years in chemical database management. Dr. Noble holds a PhD in medicinal chemistry, and his research interests include developing radiopharmaceuticals useful for mapping biological receptors. Dr. Noble was first introduced to chemical database management at GlaxoSmithKline and Eli Lilly and Company. At Gryphon, Dr. Noble supports NIAID’s ChemDB database, a chemical structure-based database containing quantitative biological information on compounds tested against HIV, tuberculosis and other related opportunistic pathogens.

Mikaela Finnegan holds a BS in biology from the University of Virginia and is currently pursuing her MS in epidemiology from George Washington University. Joining Gryphon in 2013, she has supported many disease risk assessments and decision-support tools and has gained experience in the curation and standardization of data to support those projects. Her primary interests lie in emerging infectious diseases and neglected tropical diseases.